Medication Therapy Management Survey of the Prescription Drug Plans
Steven T. Boyd, PharmD, BCPS, CDE, CDM; LeAnn C. Boyd, PharmD, BCPS, CDE, CDM; Alan J. Zillich, PharmD
J Am Pharm Assoc (2003) 2006;46:692-699. doi:10.1331/1544-3191.46.6.692.Boyd


Objective  To evaluate the preliminary development and implementation plans for medication therapy management (MTM) services across plan sponsors for the Medicare Part D Prescription Drug Plans (PDPs) and provide pharmacists with insights for MTM development.

Design  Cross-sectional survey.

Setting  United States.

Participants  307 individual contacts from Medicare Advantage or standalone PDPs.

Intervention  A survey comprising questions about the PDP demographics, plans and implementation, beneficiary eligibility criteria, scope of services, providers of services, and payment structure for MTM services was e-mailed and mailed in November 2005.

Main Outcome Measures  Descriptive and bivariate analysis of survey items.

Results  A total of 97 usable surveys were completed, a 31.5% response rate. Almost all respondents had a plan in place for MTM services. The majority of PDPs perceived that MTM would have a moderate benefit to their organization. Most PDPs planned to focus efforts on diabetes, heart failure, and other forms of cardiovascular disease. Overwhelmingly, PDPs planned to follow the Centers for Medicare & Medicaid Services (CMS) mandate for criteria regarding beneficiary eligibility. Only 8.2% of respondents planned to use a “traditional” pharmacist, such as a community, long-term care, hospital, or clinic pharmacist. The majority of PDPs (53.6%) planned to employ managed care pharmacists to administer MTM services.

Conclusion  Pharmacists are eager to implement MTM services and are looking for PDPs to provide a path of implementation and reimbursement. Many PDPs were planning to deliver MTM services internally using health professional staff, thereby limiting the extent of participation of community, long-term care, hospital and health-system, and clinic-based pharmacists. Further research and advocacy are required to ensure that MTM services accomplish the true intent of the congressional and CMS mandates.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.


Register for a FREE limited account to benefit from personalization features such as alerts.


Dobson A. Medication therapy management services: a critical review.  Lewin Group. March  2005.
Bluml BM.  Definition of medication therapy management: development of professionwide consensus.  J Am Pharm Assoc.  2005;45:566–72.[CrossRef]
 American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: core elements of an MTM service (version 1.0).  J Am Pharm Assoc.  2005;45:573–9.
 Department of Health and Human Services, Center for Medicare and Medicaid Services. Medicare program; Medicare prescription drug benefit; final rule. 70 Federal Register. 4279–4283, 4581 (2005). Accessed at http://a257.g.akamaitech.net/7/257/2422/01jan20051800/edocket.access.gpo.gov/2005/pdf/05-1321.pdf, October 6,  2006.
 Department of Health and Human Services, Center for Medicare and Medicaid Services. Medicare program; Medicare prescription drug benefit; final rule. 70 Federal Register. 4280 (2005). Accessed at http://a257.g.akamaitech.net/7/257/2422/01jan20051800/edocket.access.gpo.gov/2005/pdf/05-1321.pdf, October 6,  2006.
Dillman DA.  Mail and Internet surveys: the tailored design method. New York:  John Wiley and Sons;  2000.
 Survey Monkey, Inc. Accessed at http://surveymonkey.com/home.asp, September 29,  2006.
Touchette DR, Burns AL, Bough MA, Blackburn JC.  Survey of medication therapy management programs under Medicare Part D.  J Am Pharm Assoc. 2006;46:683–91.
Garrett D, Bluml B. Patient self-management program for diabetes: first year clinical, humanistic, and economic outcomes.  J Am Pharm Assoc.  2005;45:130–7.
Bluml B, McKenney J, Cziraky MJ.  Pharmaceutical care services and results in Project ImPACT: Hyperlipidemia.  J Am Pharm Assoc.  2000;40:157–65.
Jameson J, VanNoord G. The impact of a pharmacotherapy consultation on the cost of outcome of medical therapy.  J Fam Pract.  1995;1:469–72.
McMullin ST, Hennenfent JA.  A prospective randomization trial to assess the cost impact of pharmacist-initiated interventions.  Arch Intern Med.  1999;159:2306–9.[PubMed]
Cranor CW, Bunting BA.  The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.  J Am Pharm Assoc.  2003;43:173–90.
 The Lewin Group. Medication therapy management services: a critical review.  J Am Pharm Assoc.  2005;45:580–7.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints